Table 1 Characteristics between survivors and non-survivors with COVID-19
From: Clinical determinants for fatality of 44,672 patients with COVID-19
Characteristics | Total (n = 44,672) | Non-survivors (n = 1023) | Survivors (n = 43,649) | Fatality (%) | RR (95%CI) | p |
|---|---|---|---|---|---|---|
Age, n (%) | ||||||
 0– | 416 (0.9%) | 0 | 416 (0.9%) | 0 |  |  |
 10– | 549 (1.2%) | 1 (0.1%) | 548 (1.3%) | 0.2 |  |  |
 20– | 3619 (8.1%) | 7 (0.7%) | 3612 (8.3%) | 0.2 |  |  |
 30– | 7600 (17.0%) | 18 (1.8%) | 7582 (17.4%) | 0.2 |  |  |
 40– | 8571 (19.2%) | 38 (3.7%) | 8533 (19.5%) | 0.4 |  |  |
 50– | 10,008 (22.4%) | 130 (12.7%) | 9878 (22.6%) | 1.3 |  |  |
 60– | 8583 (19.2%) | 309 (30.2%) | 8274 (19.0%) | 3.6 |  |  |
 70– | 3918 (8.8%) | 312 (30.5%) | 3606 (8.3%) | 8.0 |  |  |
 ≥ 80 | 1408 (3.2%) | 208 (20.3%) | 1200 (2.7%) | 14.8 |  |  |
Severity*, n (%) | ||||||
 Mild/moderate | 36,160 (80.9%) | 0 | 36,160 (82.8%) | 0 |  |  |
 Severe | 6168 (13.8%) | 0 | 6168 (14.1%) | 0 |  |  |
 Critical | 2087 (4.7%) | 1023 (100%) | 1064 (2.4%) | 49.0 |  |  |
Gender, n (%) | ||||||
 Male | 22,981 (51.4%) | 653 (63.8%) | 22,328 (51.2%) | 2.8 | 1.67 (1.47–1.89) | < 0.001 |
 Female | 21,691 (48.6%) | 370 (36.2%) | 21,321 (48.8%) | 1.7 |  |  |
Comorbidity#, n (%) | ||||||
 Hypertension | 2683 (12.8%) | 161 (39.7%) | 2522 (12.3%) | 6.0 | 4.48 (3.69–5.45) | < 0.001 |
 Diabetes | 1102 (5.3%) | 80 (19.7%) | 1022 (5.0%) | 7.3 | 4.47 (3.49–5.61) | < 0.001 |
 Cardiovascular disease | 873 (4.2%) | 92 (22.7%) | 781 (3.8%) | 10.5 | 6.75 (5.40–8.43) | < 0.001 |
 Respiratory disease | 511 (2.4%) | 32 (7.9%) | 479 (2.3%) | 6.3 | 3.43 (2.42–4.87) | < 0.001 |
 Cancer | 107 (0.5%) | 6 (1.5%) | 101 (0.5%) | 5.6 | 2.93 (1.34–6.41) | 0.006 |